Article
MSH2 deficiency abolishes the anticancer and pro‐aging activity of short telomeres
5 Nov 2008
Abstract excerpt
Mutations in the mismatch repair (MMR) pathway occur in human colorectal cancers with microsatellite instability. Mounting evidence suggests that cell-cycle arrest in response to a number of cellular stresses, including telomere shortening, is a potent anticancer barrier. The telomerase-deficient mouse model illustrates the anticancer effect of cell-cycle arrest provoked by short telomeres. Here, we describe a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
